nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Stinging—Mitomycin—urinary bladder cancer	0.034	0.034	CcSEcCtD
Levobunolol—Cardiac failure congestive—Mitomycin—urinary bladder cancer	0.022	0.022	CcSEcCtD
Levobunolol—Diabetic—Methotrexate—urinary bladder cancer	0.0178	0.0178	CcSEcCtD
Levobunolol—Chest pain—Valrubicin—urinary bladder cancer	0.0149	0.0149	CcSEcCtD
Levobunolol—Stinging—Fluorouracil—urinary bladder cancer	0.0141	0.0141	CcSEcCtD
Levobunolol—Alopecia—Mitomycin—urinary bladder cancer	0.0122	0.0122	CcSEcCtD
Levobunolol—Respiratory failure—Gemcitabine—urinary bladder cancer	0.0119	0.0119	CcSEcCtD
Levobunolol—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0117	0.0117	CcSEcCtD
Levobunolol—Pain—Carboplatin—urinary bladder cancer	0.0113	0.0113	CcSEcCtD
Levobunolol—Syncope—Mitomycin—urinary bladder cancer	0.0108	0.0108	CcSEcCtD
Levobunolol—Loss of consciousness—Mitomycin—urinary bladder cancer	0.0106	0.0106	CcSEcCtD
Levobunolol—Asthenia—Valrubicin—urinary bladder cancer	0.0102	0.0102	CcSEcCtD
Levobunolol—Pruritus—Valrubicin—urinary bladder cancer	0.0101	0.0101	CcSEcCtD
Levobunolol—Confusional state—Mitomycin—urinary bladder cancer	0.0099	0.0099	CcSEcCtD
Levobunolol—Diarrhoea—Valrubicin—urinary bladder cancer	0.00975	0.00975	CcSEcCtD
Levobunolol—Shock—Mitomycin—urinary bladder cancer	0.00966	0.00966	CcSEcCtD
Levobunolol—Cardiac arrest—Thiotepa—urinary bladder cancer	0.00955	0.00955	CcSEcCtD
Levobunolol—Ataxia—Thiotepa—urinary bladder cancer	0.00944	0.00944	CcSEcCtD
Levobunolol—Dizziness—Valrubicin—urinary bladder cancer	0.00942	0.00942	CcSEcCtD
Levobunolol—Cardiac failure congestive—Gemcitabine—urinary bladder cancer	0.00931	0.00931	CcSEcCtD
Levobunolol—Headache—Valrubicin—urinary bladder cancer	0.00892	0.00892	CcSEcCtD
Levobunolol—Dyspnoea—Mitomycin—urinary bladder cancer	0.00875	0.00875	CcSEcCtD
Levobunolol—Cardiac failure congestive—Cisplatin—urinary bladder cancer	0.00868	0.00868	CcSEcCtD
Levobunolol—Nasal congestion—Cisplatin—urinary bladder cancer	0.00864	0.00864	CcSEcCtD
Levobunolol—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.00862	0.00862	CcSEcCtD
Levobunolol—Keratitis—Epirubicin—urinary bladder cancer	0.00859	0.00859	CcSEcCtD
Levobunolol—Lethargy—Fluorouracil—urinary bladder cancer	0.00848	0.00848	CcSEcCtD
Levobunolol—Nausea—Valrubicin—urinary bladder cancer	0.00846	0.00846	CcSEcCtD
Levobunolol—Pain—Mitomycin—urinary bladder cancer	0.00839	0.00839	CcSEcCtD
Levobunolol—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00809	0.00809	CcSEcCtD
Levobunolol—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.00803	0.00803	CcSEcCtD
Levobunolol—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.00795	0.00795	CcSEcCtD
Levobunolol—Keratitis—Doxorubicin—urinary bladder cancer	0.00795	0.00795	CcSEcCtD
Levobunolol—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.0079	0.0079	CcSEcCtD
Levobunolol—Ataxia—Fluorouracil—urinary bladder cancer	0.00781	0.00781	CcSEcCtD
Levobunolol—Conjunctivitis—Thiotepa—urinary bladder cancer	0.00752	0.00752	CcSEcCtD
Levobunolol—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00718	0.00718	CcSEcCtD
Levobunolol—Asthenia—Mitomycin—urinary bladder cancer	0.00704	0.00704	CcSEcCtD
Levobunolol—Stinging—Epirubicin—urinary bladder cancer	0.00688	0.00688	CcSEcCtD
Levobunolol—Cardiac arrest—Etoposide—urinary bladder cancer	0.00686	0.00686	CcSEcCtD
Levobunolol—Diarrhoea—Mitomycin—urinary bladder cancer	0.00671	0.00671	CcSEcCtD
Levobunolol—Dizziness—Mitomycin—urinary bladder cancer	0.00649	0.00649	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.00645	0.00645	CcSEcCtD
Levobunolol—Stinging—Doxorubicin—urinary bladder cancer	0.00636	0.00636	CcSEcCtD
Levobunolol—Conjunctivitis—Fluorouracil—urinary bladder cancer	0.00622	0.00622	CcSEcCtD
Levobunolol—Arrhythmia—Thiotepa—urinary bladder cancer	0.00621	0.00621	CcSEcCtD
Levobunolol—Headache—Mitomycin—urinary bladder cancer	0.00615	0.00615	CcSEcCtD
Levobunolol—Alopecia—Thiotepa—urinary bladder cancer	0.00614	0.00614	CcSEcCtD
Levobunolol—Bronchospasm—Etoposide—urinary bladder cancer	0.00613	0.00613	CcSEcCtD
Levobunolol—Respiratory failure—Methotrexate—urinary bladder cancer	0.00606	0.00606	CcSEcCtD
Levobunolol—Conjunctivitis—Cisplatin—urinary bladder cancer	0.0059	0.0059	CcSEcCtD
Levobunolol—Nausea—Mitomycin—urinary bladder cancer	0.00583	0.00583	CcSEcCtD
Levobunolol—Atrioventricular block—Epirubicin—urinary bladder cancer	0.00574	0.00574	CcSEcCtD
Levobunolol—Bradycardia—Cisplatin—urinary bladder cancer	0.00555	0.00555	CcSEcCtD
Levobunolol—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00553	0.00553	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00551	0.00551	CcSEcCtD
Levobunolol—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.00531	0.00531	CcSEcCtD
Levobunolol—Visual impairment—Cisplatin—urinary bladder cancer	0.00525	0.00525	CcSEcCtD
Levobunolol—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00522	0.00522	CcSEcCtD
Levobunolol—Alopecia—Gemcitabine—urinary bladder cancer	0.00516	0.00516	CcSEcCtD
Levobunolol—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00513	0.00513	CcSEcCtD
Levobunolol—Alopecia—Fluorouracil—urinary bladder cancer	0.00508	0.00508	CcSEcCtD
Levobunolol—Confusional state—Thiotepa—urinary bladder cancer	0.00498	0.00498	CcSEcCtD
Levobunolol—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.00497	0.00497	CcSEcCtD
Levobunolol—Arrhythmia—Cisplatin—urinary bladder cancer	0.00487	0.00487	CcSEcCtD
Levobunolol—Alopecia—Cisplatin—urinary bladder cancer	0.00481	0.00481	CcSEcCtD
Levobunolol—Erythema multiforme—Etoposide—urinary bladder cancer	0.00472	0.00472	CcSEcCtD
Levobunolol—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.00465	0.00465	CcSEcCtD
Levobunolol—Visual disturbance—Methotrexate—urinary bladder cancer	0.00456	0.00456	CcSEcCtD
Levobunolol—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.00446	0.00446	CcSEcCtD
Levobunolol—Paraesthesia—Thiotepa—urinary bladder cancer	0.00443	0.00443	CcSEcCtD
Levobunolol—Alopecia—Etoposide—urinary bladder cancer	0.00441	0.00441	CcSEcCtD
Levobunolol—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.00441	0.00441	CcSEcCtD
Levobunolol—Lethargy—Methotrexate—urinary bladder cancer	0.00441	0.00441	CcSEcCtD
Levobunolol—Chest pain—Gemcitabine—urinary bladder cancer	0.00433	0.00433	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.0043	0.0043	CcSEcCtD
Levobunolol—Chest pain—Fluorouracil—urinary bladder cancer	0.00426	0.00426	CcSEcCtD
Levobunolol—Pain—Thiotepa—urinary bladder cancer	0.00422	0.00422	CcSEcCtD
Levobunolol—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00414	0.00414	CcSEcCtD
Levobunolol—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Levobunolol—Lethargy—Epirubicin—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Levobunolol—Confusional state—Fluorouracil—urinary bladder cancer	0.00412	0.00412	CcSEcCtD
Levobunolol—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00407	0.00407	CcSEcCtD
Levobunolol—Ataxia—Methotrexate—urinary bladder cancer	0.00406	0.00406	CcSEcCtD
Levobunolol—Diplopia—Epirubicin—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Levobunolol—Urticaria—Thiotepa—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Levobunolol—Hypotension—Gemcitabine—urinary bladder cancer	0.00388	0.00388	CcSEcCtD
Levobunolol—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00384	0.00384	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Levobunolol—Loss of consciousness—Etoposide—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Levobunolol—Hypotension—Fluorouracil—urinary bladder cancer	0.00381	0.00381	CcSEcCtD
Levobunolol—Ataxia—Epirubicin—urinary bladder cancer	0.0038	0.0038	CcSEcCtD
Levobunolol—Diplopia—Doxorubicin—urinary bladder cancer	0.00374	0.00374	CcSEcCtD
Levobunolol—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00373	0.00373	CcSEcCtD
Levobunolol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Levobunolol—Chest pain—Etoposide—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Levobunolol—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00367	0.00367	CcSEcCtD
Levobunolol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Levobunolol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Levobunolol—Hypotension—Cisplatin—urinary bladder cancer	0.00362	0.00362	CcSEcCtD
Levobunolol—Confusional state—Etoposide—urinary bladder cancer	0.00357	0.00357	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00356	0.00356	CcSEcCtD
Levobunolol—Pain—Gemcitabine—urinary bladder cancer	0.00355	0.00355	CcSEcCtD
Levobunolol—Asthenia—Thiotepa—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—urinary bladder cancer	0.00352	0.00352	CcSEcCtD
Levobunolol—Pruritus—Thiotepa—urinary bladder cancer	0.00349	0.00349	CcSEcCtD
Levobunolol—Pain—Fluorouracil—urinary bladder cancer	0.00349	0.00349	CcSEcCtD
Levobunolol—Paraesthesia—Cisplatin—urinary bladder cancer	0.00347	0.00347	CcSEcCtD
Levobunolol—Dyspnoea—Cisplatin—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Levobunolol—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Levobunolol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Levobunolol—Diarrhoea—Thiotepa—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Levobunolol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00336	0.00336	CcSEcCtD
Levobunolol—Depression—Methotrexate—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Levobunolol—Hypotension—Etoposide—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Levobunolol—Pain—Cisplatin—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Levobunolol—Dizziness—Thiotepa—urinary bladder cancer	0.00326	0.00326	CcSEcCtD
Levobunolol—Urticaria—Fluorouracil—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Levobunolol—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Levobunolol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Levobunolol—Paraesthesia—Etoposide—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Levobunolol—Dyspnoea—Etoposide—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Levobunolol—Headache—Thiotepa—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Levobunolol—Pain—Etoposide—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Levobunolol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Levobunolol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Levobunolol—Asthenia—Gemcitabine—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Levobunolol—Pruritus—Gemcitabine—urinary bladder cancer	0.00294	0.00294	CcSEcCtD
Levobunolol—Nausea—Thiotepa—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Levobunolol—Feeling abnormal—Etoposide—urinary bladder cancer	0.00292	0.00292	CcSEcCtD
Levobunolol—Pruritus—Fluorouracil—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Levobunolol—Visual impairment—Methotrexate—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Levobunolol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Levobunolol—Bradycardia—Epirubicin—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Levobunolol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Levobunolol—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Levobunolol—Urticaria—Etoposide—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Levobunolol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Levobunolol—Asthenia—Cisplatin—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Levobunolol—Dizziness—Fluorouracil—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Levobunolol—Visual impairment—Epirubicin—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Levobunolol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Levobunolol—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Levobunolol—Alopecia—Methotrexate—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Levobunolol—Hypersensitivity—Etoposide—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Levobunolol—Headache—Gemcitabine—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Levobunolol—Headache—Fluorouracil—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Levobunolol—Asthenia—Etoposide—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Levobunolol—Pruritus—Etoposide—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Levobunolol—Arrhythmia—Epirubicin—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Levobunolol—Alopecia—Epirubicin—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Levobunolol—Nausea—Gemcitabine—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Levobunolol—Diarrhoea—Etoposide—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Levobunolol—Nausea—Fluorouracil—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Levobunolol—Dizziness—Etoposide—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Levobunolol—Nausea—Cisplatin—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Levobunolol—Alopecia—Doxorubicin—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Levobunolol—Headache—Etoposide—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Levobunolol—Chest pain—Methotrexate—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Levobunolol—Syncope—Epirubicin—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Levobunolol—Palpitations—Epirubicin—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Levobunolol—Confusional state—Methotrexate—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Levobunolol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Levobunolol—Nausea—Etoposide—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Levobunolol—Chest pain—Epirubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Levobunolol—Confusional state—Epirubicin—urinary bladder cancer	0.002	0.002	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Levobunolol—Hypotension—Methotrexate—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Levobunolol—Shock—Epirubicin—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Levobunolol—Chest pain—Doxorubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Levobunolol—Paraesthesia—Methotrexate—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Levobunolol—Dyspnoea—Methotrexate—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Levobunolol—Hypotension—Epirubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Levobunolol—Pain—Methotrexate—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Levobunolol—Shock—Doxorubicin—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Levobunolol—Paraesthesia—Epirubicin—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Levobunolol—Dyspnoea—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Levobunolol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Levobunolol—Pain—Epirubicin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Levobunolol—Urticaria—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Levobunolol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Levobunolol—Urticaria—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Levobunolol—Pain—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Levobunolol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Levobunolol—Asthenia—Methotrexate—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Levobunolol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Levobunolol—Pruritus—Methotrexate—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Levobunolol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Levobunolol—Diarrhoea—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Levobunolol—Asthenia—Epirubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Levobunolol—Pruritus—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Levobunolol—Dizziness—Methotrexate—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Levobunolol—Diarrhoea—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Levobunolol—Headache—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Levobunolol—Dizziness—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Levobunolol—Nausea—Methotrexate—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Levobunolol—Headache—Epirubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Levobunolol—Nausea—Epirubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Levobunolol—Headache—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
